QuadraMed to Present at FBR 2006 Growth Investor Conference Thursday June 1
June 01 2006 - 8:15AM
Business Wire
QuadraMed(R) Corporation (Amex:QD) today announced that Keith B.
Hagen, QuadraMed President and CEO, will present the company's
strategy and financial performance at the FBR 2006 Growth Investor
Conference on Thursday, June 1, 2006 at 9:45 a.m. ET. The two-day,
invitation only conference is being sponsored by Friedman,
Billings, Ramsey & Co., Inc., and is being held at the Grand
Hyatt New York, New York. Investors and other interested parties
are invited to attend the 40-minute presentation via a live
Webcast. To attend, go to the conference homepage at
http://www.fbr.com/growth06 and click on "Webcast" to register at
least five minutes before the presentation begins 9:45 a.m. After
registration, click on the Room 9 "QD" presentation link. The
QuadraMed presentation will also be posted to the "Investor"
section of the company website, www.quadramed.com, immediately
following the webcast. About QuadraMed Corporation QuadraMed
Corporation advances the success of healthcare organizations
through IT solutions that leverage quality care into positive
financial outcomes. As evolving reimbursement scenarios challenge
healthcare organizations to leverage quality of care into payment,
clients committing to QuadraMed's care-based solutions can realize
market leading financial performance. Using QuadraMed's end-to-end
solutions to optimize the patient experience and leverage quality
of care into payment, our clients can receive the proper
reimbursement, in the shortest time, at the lowest administrative
cost. Behind our products and services is a staff of almost 600
professionals whose experience and dedication to service have
earned QuadraMed the trust and loyalty of customers at
approximately 2,000 healthcare provider facilities. To find out
more about QuadraMed, visit www.quadramed.com. Cautionary Statement
on Risks Associated with QuadraMed's Forward-Looking Statements
This press release contains forward-looking statements, as defined
in Section 27A of the Securities Act of 1933 and Section 21E of the
Securities Exchange Act of 1934, by QuadraMed that are subject to
risks and uncertainties. The words "believe," "expect,"
"anticipate," "intend," "plan," "estimate," "may," "should,"
"could," and similar expressions are intended to identify such
statements. Forward-looking statements are not guarantees of future
performance and are to be interpreted only as of the date on which
they are made. QuadraMed undertakes no obligation to update or
revise any forward-looking statement except as required by law.
QuadraMed advises investors that it discusses risk factors and
uncertainties that could cause QuadraMed's actual results to differ
from forward-looking statements in its periodic reports filed with
the Securities and Exchange Commission ("SEC"). QuadraMed's SEC
filings can be accessed through the Investor Relations section of
our website, www.quadramed.com, or through the SEC's EDGAR Database
at www.sec.gov (QuadraMed has EDGAR CIK No. 0001018833). QuadraMed
is a registered trademark of QuadraMed Corporation. All other
trademarks are the property of their respective holders.
Quadramed (AMEX:QD)
Historical Stock Chart
From Jun 2024 to Jul 2024
Quadramed (AMEX:QD)
Historical Stock Chart
From Jul 2023 to Jul 2024